Masimo Corp. (Nasdaq: MASI), an Irvine-based medical device maker best known for making health monitoring devices for hospitals, today officially launched its W1 health watch for consumer use.
“The first of its kind, the Masimo W1 offers accurate, continuous measurements and insightful health data – from the leader in hospital pulse oximetry – in a personal, lifestyle-friendly, wrist-worn wearable,” the company said in a press release.
The watch, which retails for $499, can take 86,400 measurements a day for rates on pulse, oxygen saturation and heart, among other features.
The company also announced a monthly subscription plan for $7.99 or $18.99 that can include insights into health trends and sleep analysis.
“Based on the feedback we have received from those who have tested Masimo W1 during the limited market release phase, we believe this watch will improve lives,” Masimo founder and Chief Executive Joe Kiani said in a statement.
The Business Journal published an in-depth article on Masimo’s pivot towards consumer devices in its Aug. 22 print issue.
Shares of Masimo fell 1.8% to $146.89 and a $7.7 billion market cap.